StockNews.com lowered shares of Electromed (NYSE:ELMD – Free Report) from a strong-buy rating to a buy rating in a research note published on Friday morning. Separately, TheStreet upgraded Electromed from a c+ rating to a b- rating in a research note on Wednesday, February 21st. Read Our Latest Stock Report on ELMD Electromed Stock Performance […]
StockNews.com cut shares of Electromed (NYSE:ELMD – Free Report) from a strong-buy rating to a buy rating in a research note published on Friday. Separately, TheStreet upgraded shares of Electromed from a c+ rating to a b- rating in a research note on Wednesday, February 21st. View Our Latest Stock Report on Electromed Electromed Price […]
StockNews.com lowered shares of Electromed (NYSE:ELMD – Free Report) from a strong-buy rating to a buy rating in a report published on Thursday. Separately, TheStreet raised Electromed from a c+ rating to a b- rating in a report on Wednesday, February 21st. Get Our Latest Report on ELMD Electromed Stock Performance ELMD stock opened at […]
Electromed (NYSE:ELMD – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued on Thursday. Separately, TheStreet raised shares of Electromed from a “c+” rating to a “b-” rating in a research note on Wednesday, February 21st. View Our Latest Report […]
Electromed, Inc. (AMEX:ELMD) Q2 2024 Earnings Call Transcript February 13, 2024 Electromed, Inc. beats earnings expectations. Reported EPS is $0.19, expectations were $0.1. ELMD isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to the Electromed Second Quarter […]
Electromed (NYSE:ELMD – Get Free Report) and NovoCure (NASDAQ:NVCR – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations. Institutional & Insider Ownership 26.7% of Electromed shares are […]
Electromed (NYSE:ELMD – Get Free Report) and LivaNova (NASDAQ:LIVN – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings. Valuation and Earnings This table compares Electromed and LivaNova’s revenue, […]
Equities research analysts at StockNews.com assumed coverage on shares of Electromed (NYSE:ELMD – Get Free Report) in a report released on Thursday. The brokerage set a “strong-buy” rating on the stock. Separately, TheStreet lowered shares of Electromed from a “b-” rating to a “c+” rating in a research report on Monday, July 31st. Check Out […]